The vision of Life Science Leader is to help facilitate connections and foster collaborations in pharma and med device development to get more life-saving and life-improving therapies to market in an efficient manner. Connect, Collaborate, Contribute
Issue link: https://lifescienceleadermag.epubxp.com/i/266911
QUALITY RELIABILITY PRODUCTIVITY REGULATORY INNOVATION K E Y W W W.C R O L E A D E R S H I PA W A R D S .C O M 2014 CRO LEADERSHIP AWARDS WINNERS Company Profiles LIFESCIENCELEADER.COM THE CRO LEADERSHIP AWARDS 2014 30 SERVICES & CAPABILITIES: PRA provides comprehensive clinical trial and strategic/ e mbedded staffing services across all phases. We also offer integrated bioanalytical laboratories, on-site pharmacies, and clinical facilities in both Europe and North America. THERAPEUTIC AREAS: Neurosciences (CNS), oncology/hematology, infectious diseases, cardio- metabolic, psychiatry, respiratory, genitourinary, endocrinology, gastroenterology, immunology, hepatology, dermatology, biosimilar products, cardio-metabolic diseases, and rare diseases "Quality is the single most important element in PRA. Quality is deeply ingrained in every PRA process and every system. It is our devoted PRA colleagues that drive quality throughout the company as we continuously challenge ourselves to improve and innovate. PRA is dedicated to work in close partnership with emerging biotech companies to successfully bring powerful new lifesaving medicines and devices to the patients who need them." SERVICES & CAPABILITIES: Bioanalytical: small molecules, peptides, large molecules, antibody drug conjugates, oligonucleotides, elements & elemental tags, biomarkers; Clinical: study design & protocol writing, clinical conduct, clinical project management, site management & monitoring, data management, biostatistics, CDISC-compliant clinical study reports; Preclinical: IND program management, ADME, neuropharmacology, general toxicology, reproductive t oxicology THERAPEUTIC AREAS: CNS disorders/neurode- generative diseases, asthma/COPD, immunol- ogy/autoimmune disease/rheumatoid arthritis, inflammatory diseases/immune status/cell response, infectious disease, dermatology, oncol- ogy, allergy, anemia, bone disease/metabolism, cardiovascular disease, diabetes/obesity/lipid metabolism/carbohydrate metabolism, female healthcare/gynecological, endocrinology/repro- ductive endocrinology, gastrointestinal disorders, h emostasis "I am pleased and proud of QPS employees for consistently delivering the highest grade of discovery, preclinical, and clinical drug development services. Their exceptional performance and dedication are underscored by this CRO Leadership Award. Through continual enhancements in our capacities and resources, we stand tall in our commitment to deliver superior science, quality, skilled performance, and trusted service to our valued customers. We are well-positioned to succeed in realizing our corporate vision: to become a global leader in contract research." "We are excited to hear that Quanticate has been recognized for quality, reliability, regulatory, productivity, and innovation. Our customers are consistently telling us that we are leading the industry in terms of our focus on quality and timeliness. Our current position as a leading global data-focused CRO is testament to the quality and reliability of our teams, who are able to utilize innovative solutions, such as our QuantiCliQ data visualization solution, to enable us to excel." DRUG LIFE CYCLE STAGES: Research & Development: Clinical (Phase 1, Phase 2, Phase 3) Formulated Drug Production: Logistics DRUG LIFE CYCLE STAGES: Research & Development: Discovery, Preclinical, Clinical (Phase 1, Phase 2, Phase 3) MAIN SERVICE AREAS: Bioanalytical, Clinical MAIN SERVICE AREAS: Bioanalytical, Clinical, Preclinical SERVICES & CAPABILITIES: Global Clinical Research Organization (CRO) primarily focused on the management, analysis, and reporting of data from clinical trials and post-marketing surveillance. Core services include clinical data management, biostatistics, programming, medical writing, pharmacovigilance and consultancy. THERAPEUTIC AREAS: Experience across all therapeutic areas MAIN SERVICE AREAS: Clinical DRUG LIFE CYCLE STAGES: Research & Development: Clinical (Phase 1, Phase 2, Phase 3) COLIN SHANNON President and CEO DR. BEN CHIEN CEO DAVID UNDERWOOD President and CEO CATEGORIES WON CATEGORIES WON: CATEGORIES WON Quanticate Hitchin, Hertfordshire, U.K. www.quanticate.com +44 (0)1462 440084 Daniel Chapple Daniel.Chapple@quanticate.com Key locations: India, South Africa, Poland, United Kingdom, and United States QPS Holdings, LLC Newark, DE www.qps.com +1 302 369 5601 Livia Legg, VP and Head of Global Business Dev. livia.legg@qps.com Key locations: Delaware, Florida, Missouri, North Carolina, U.S.A.; Graz, Austria; Groningen, The Netherlands; Hyderabad, India; Taipei, Taiwan PRA Raleigh, NC www.praintl.com +1 919 786 8200 Roger Boutin BoutinRoger@PRAIntl.com Key locations: Buenos Aires, Argentina; Johannesburg, South Africa; Mannheim, Germany; Moscow, Russian Federation; Raleigh, NC; Singapore; Victoria, British Columbia, Canada; Zuidlaren/Assen/Groningen, The Netherlands 2 0 1 4 L S L C R O C o m p a n y P r o f i l e L a y o u t T h a t N i c e . i n d d 1 2 2014 LSL CRO Company Profile Layout That Nice.indd 12 2 / 2 2 / 2 0 1 4 1 : 4 3 : 2 8 P M 2/22/2014 1:43:28 PM